Seer (SEER) Current Assets (2020 - 2026)
Seer (SEER) posted quarterly Current Assets of $181.6 million for Q1 2026, down 28.86% year-over-year from $255.3 million in Q1 2025, and down 9.89% quarter-over-quarter from $201.5 million in Q4 2025.
Seer (SEER) Current Assets (2020 - 2026) Analysis & Trends
Seer's Current Assets history runs 7 years deep, the most recent figure standing at $181.6 million for Q1 2026.
- In Q1 2026, Current Assets fell 28.86% year-over-year to $181.6 million; the TTM figure through Mar 2026 stood at $181.6 million (down 28.86% YoY), while the FY2025 annual figure was $201.5 million, down 20.44% from the prior year.
- Current Assets for Q1 2026 stood at $181.6 million, down from $201.5 million in the prior quarter.
- The five-year high for Current Assets was $466.8 million in Q2 2022, with the low at $181.6 million in Q1 2026.
- The 5-year median for Current Assets is $324.2 million (2024), against an average of $318.2 million.
- The sharpest annual moves came in 2022 and 2026: Current Assets grew 5.66% in 2022, then declined 28.86% in 2026.
- Seer's Current Assets stood at $435.0 million in 2022, then fell by 24.02% to $330.5 million in 2023, then retreated by 23.35% to $253.3 million in 2024, then decreased by 20.44% to $201.5 million in 2025, then fell by 9.89% to $181.6 million in 2026.
- Business Quant data shows SEER's Current Assets at $181.6 million in Q1 2026, $201.5 million in Q4 2025, and $214.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 166.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 166.10 Mn |
| Mar 31, 2026 | 181.59 Mn |
| Dec 31, 2025 | 201.53 Mn |
| Sep 30, 2025 | 214.36 Mn |
| Jun 30, 2025 | 225.64 Mn |
| Mar 31, 2025 | 255.27 Mn |
| Dec 31, 2024 | 253.32 Mn |
| Sep 30, 2024 | 264.10 Mn |
| Jun 30, 2024 | 299.69 Mn |
| Mar 31, 2024 | 324.15 Mn |
| Dec 31, 2023 | 330.51 Mn |
| Sep 30, 2023 | 346.12 Mn |
| Jun 30, 2023 | 335.38 Mn |
| Mar 31, 2023 | 367.38 Mn |
| Dec 31, 2022 | 434.98 Mn |
| Sep 30, 2022 | 450.47 Mn |
| Jun 30, 2022 | 466.76 Mn |
| Mar 31, 2022 | 457.46 Mn |
| Dec 31, 2021 | 411.70 Mn |
| Sep 30, 2021 | 514.27 Mn |